Juan Antonio K. Chong Chie

The paper evaluates neuro-metabolic and vascular dysregulation in mice post-TBI, finding sex- and injury side-dependent changes that suggest MVD as a potential biomarker.

This study combines clinical cognitive assessments and neuro-metabolic vascular data to predict Alzheimer's disease stage and grade independently of amyloid and tau.

This study uses metabolic covariance analysis on ADNI PET data to identify stage-specific biomarker signatures in Alzheimer's disease progression.

This study identifies neuro-metabolic and vascular dysfunction (MVD) as an early indicator of Alzheimer's disease by analyzing clinical data from ADNI.

This paper characterizes cerebrovascular phenotypes in WSB.APP/PS1 mice, showing age-related CAA, transcriptomic overlap with human AD, myelin deficits, and APOE allele-dependent effects on vascular pathology.